Your browser doesn't support javascript.
loading
Protocol for a Randomized Controlled Trial to Evaluate a Permissive Blood Pressure Target Versus Usual Care in Critically Ill Children with Hypotension (PRESSURE).
Darnell, Robert; Brown, Alanna; Laing, Emma; Edwards, Julia; Harrison, David A; Manning, Joseph C; Peters, Mark J; Ramnarayan, Padmanabhan; Ray, Samiran; Sadique, Zia; Scholefield, Barnaby R; Shortt, Dermot; Lampro, Lamprini; Au, Carly; Rowan, Kathy M; Mouncey, Paul; Inwald, David P.
Afiliação
  • Darnell R; Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Brown A; Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Laing E; Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Edwards J; Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Harrison DA; Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Manning JC; School of Healthcare, College of Life Sciences, University of Leicester, Leicester, United Kingdom.
  • Peters MJ; Infection, Immunity and Inflammation, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Ramnarayan P; Department of Surgery and Cancer, Imperial College London, St Mary's Campus, London, United Kingdom.
  • Ray S; Infection, Immunity and Inflammation, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Sadique Z; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Scholefield BR; Department of Paediatric Critical Care Medicine, Hospital for Sick Children, University Avenue, Toronto, ON, Canada.
  • Shortt D; Patient representative, c/o Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Lampro L; Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Au C; Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Rowan KM; Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Mouncey P; Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
  • Inwald DP; Paediatric Intensive Care Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Pediatr Crit Care Med ; 25(7): 629-637, 2024 Jul 01.
Article em En | MEDLINE | ID: mdl-38629915
ABSTRACT

OBJECTIVES:

Management of hypotension is a fundamental part of pediatric critical care, with cardiovascular support in the form of fluids or vasoactive drugs offered to every hypotensive child. However, optimal blood pressure (BP) targets are unknown. The PRotocolised Evaluation of PermiSSive BP Targets Versus Usual CaRE (PRESSURE) trial aims to evaluate the clinical and cost-effectiveness of a permissive mean arterial pressure (MAP) target of greater than a fifth centile for age compared with usual care.

DESIGN:

Pragmatic, open, multicenter, parallel-group randomized control trial (RCT) with integrated economic evaluation.

SETTING:

Eighteen PICUs across the United Kingdom. PATIENTS Infants and children older than 37 weeks corrected gestational age to 16 years accepted to a participating PICU, on mechanical ventilation and receiving vasoactive drugs for hypotension.

INTERVENTIONS:

Adjustment of hemodynamic support to achieve a permissive MAP target greater than fifth centile for age during invasive mechanical ventilation. MEASUREMENTS AND MAIN

RESULTS:

Randomization is 11 to a permissive MAP target or usual care, stratified by site and age group. Due to the emergency nature of the treatment, approaching patients for written informed consent will be deferred until after randomization. The primary clinical outcome is a composite of death and days of ventilatory support at 30 days. Baseline demographics and clinical status will be recorded as well as daily measures of BP and organ support, and discharge outcomes. This RCT received Health Research Authority approval (reference 289545), and a favorable ethical opinion from the East of England-Cambridge South Research Ethics Committee on May 10, 2021 (reference number 21/EE/0084). The trial is registered and has an International Standard RCT Number (reference 20609635).

CONCLUSIONS:

Trial findings will be disseminated in U.K. national and international conferences and in peer-reviewed journals.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Respiração Artificial / Unidades de Terapia Intensiva Pediátrica / Estado Terminal / Hipotensão Limite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn País/Região como assunto: Europa Idioma: En Revista: Pediatr Crit Care Med Assunto da revista: PEDIATRIA / TERAPIA INTENSIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Respiração Artificial / Unidades de Terapia Intensiva Pediátrica / Estado Terminal / Hipotensão Limite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn País/Região como assunto: Europa Idioma: En Revista: Pediatr Crit Care Med Assunto da revista: PEDIATRIA / TERAPIA INTENSIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido